American Oncology Network (AON), one of the fastest-growing community oncology networks in the nation, announced today that ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, ...

Almost three-quarters of people incarcerated in Irish prisons have some form of substance addiction – but face long waits for ...

Notes and letters were written by hand or typed afterwards, placed in an envelope, and sent by post. Later, notes were ...

Jean-Claude Saghbini is the Chief Technology Officer and President of Lumeris Technology, driving Tom™ – Lumeris' AI-powered Primary Care as a Service platform, delivering scalable, coordinated, and ...

At Newsweek's Digital Health Care Forum, industry leaders discussed the challenges of seamless data-sharing, including AI ...

Background Diabetes mellitus (DM) is a common comorbidity in hypertrophic cardiomyopathy (HCM) and may exacerbate arrhythmic ...

Transporeon, a Trimble Company, today announced the launch of its new Transport Planner tool, which delivers optimal ...

High-paying remote finance director jobs often involve managing accounting and financial control functions, establishing ...

Taysha Gene Therapies stock surges after FDA alignment on a pivotal Rett Syndrome study. Read the latest analysis on TSHA ...

Artificial intelligence and analytics platforms seek to help providers improve compliance, patient care experience and ...

Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated in Part A of the REVEAL Phase 1/2 trials Finalized FDA ...